|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
1656478838 |
| 003 |
DE-627 |
| 005 |
20230426095515.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
160425r20162015xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a urn:nbn:de:bsz:16-heidok-194475
|2 urn
|
| 024 |
7 |
|
|a 10.1186/s13063-015-0626-0
|2 doi
|
| 035 |
|
|
|a (DE-627)1656478838
|
| 035 |
|
|
|a (DE-576)468981403
|
| 035 |
|
|
|a (DE-599)BSZ468981403
|
| 035 |
|
|
|a (OCoLC)949960673
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 610
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 100 |
1 |
|
|a Nashan, Björn
|d 1960-
|e VerfasserIn
|0 (DE-588)13045902X
|0 (DE-627)501603069
|0 (DE-576)298208563
|4 aut
|
| 245 |
1 |
0 |
|a Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients
|b study protocol for a randomized controlled trial
|c Björn Nashan, Peter Schemmer, Felix Braun, Markus Dworak, Peter Wimmer and Hans Schlitt
|
| 264 |
|
1 |
|a London
|b BioMed Central
|c 2016
|
| 300 |
|
|
|a 1 Online-Ressource (10 Seiten)
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Wissenschaftlicher Aufsatz. - Aus: Trials, 16 (2015), Nr. 118. pp. 1-10. ISSN 1468-6694
|
| 534 |
|
|
|c 2015
|
| 700 |
1 |
|
|a Schemmer, Peter
|d 1967-
|e VerfasserIn
|0 (DE-588)1022604244
|0 (DE-627)717006794
|0 (DE-576)365668230
|4 aut
|
| 856 |
4 |
0 |
|u http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-194475
|q application/pdf
|x Resolving-System
|z kostenfrei
|3 Volltext
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20160425
|
| 993 |
|
|
|a Article
|
| 994 |
|
|
|a 2015
|
| 998 |
|
|
|g 1022604244
|a Schemmer, Peter
|m 1022604244:Schemmer, Peter
|d 910000
|d 910200
|e 910000PS1022604244
|e 910200PS1022604244
|k 0/910000/
|k 1/910000/910200/
|p 2
|
| 999 |
|
|
|a KXP-PPN1656478838
|e 3388129274
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"title":[{"title_sort":"Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients","subtitle":"study protocol for a randomized controlled trial","title":"Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients"}],"origin":[{"publisher":"BioMed Central","dateIssuedKey":"2016","dateIssuedDisp":"2016","publisherPlace":"London"}],"id":{"uri":["urn:nbn:de:bsz:16-heidok-194475"],"doi":["10.1186/s13063-015-0626-0"],"eki":["1656478838"]},"person":[{"family":"Nashan","given":"Björn","display":"Nashan, Björn","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Schemmer","given":"Peter","roleDisplay":"VerfasserIn","display":"Schemmer, Peter","role":"aut"}],"name":{"displayForm":["Björn Nashan, Peter Schemmer, Felix Braun, Markus Dworak, Peter Wimmer and Hans Schlitt"]},"type":{"bibl":"book","media":"Online-Ressource"},"note":["Wissenschaftlicher Aufsatz. - Aus: Trials, 16 (2015), Nr. 118. pp. 1-10. ISSN 1468-6694"],"physDesc":[{"extent":"1 Online-Ressource (10 Seiten)"}],"recId":"1656478838","language":["eng"]}
|
| SRT |
|
|
|a NASHANBJOEEVALUATING2016
|
